10x Genomics (NASDAQ:TXG - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.19. The firm had revenue of $150.84 million during the quarter, compared to analyst estimates of $146.41 million. 10x Genomics had a negative return on equity of 6.89% and a negative net margin of 6.77%.The company's revenue was up 9.4% on a year-ov…